Trump’s Proposed Pharmaceutical Tariffs: National Security or Price Spike for American Families?

President Donald Trump’s latest trade gambit targets the pharmaceutical industry with plans to impose tariffs that could soar as high as 200% on imported medicines. Ostensibly a move to protect national security and bring drug manufacturing back to American soil, this aggressive strategy raises a critical question: at what cost to the average American? Is Tariff Shock the Price We Pay for Sovereignty? For decades, the United States has enjoyed duty-free access to foreign-made pharmaceuticals, relying heavily on global supply chains concentrated in countries like China and India. But as geopolitical tensions escalate and dependence on adversarial nations becomes glaringly...